1
|
Labe S, Jones G, Dailey H, Bhasker J, Kanwar R, Crago M, Fitzgerald B, Mikhail D, Hafiz S, Kramer C, Zhu J, Vasekar M. D-CRSE: Diminishing chemotherapy-related side effects through patient education, a mixed-methods pilot study. J Psychosoc Oncol 2024:1-15. [PMID: 38684105 DOI: 10.1080/07347332.2024.2345124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2024]
Abstract
OBJECTIVES Patient education materials regarding self-management of chemotherapy-related side effects are limited, which may result in patients using disreputable sources. We created a brochure that educates patients on common side effects, tools to address problems themselves, and guidance on when to contact their oncologist or seek emergency care. This mixed-methods study conducted at Penn State Cancer Institute evaluates the feasibility of using an educational brochure to improve patient outcomes through education. METHODS Chemotherapy naïve patients with breast or gastrointestinal (GI) cancer were enrolled in a single-arm clinical trial from December 2021 to 2022. Participants received the educational brochure and were asked to provide their initial impressions. They completed The Emotional Thermometer Scale (ETS) and the Memorial Symptom Assessment Scale (MSAS) to measure changes in patient symptoms and mental health throughout their chemotherapy course at 0, 6, and 12-week intervals. The drop-out rate was recorded as a measure of study feasibility. RESULTS The study participants were split between the following cancer types: 77.8% breast and 22.2% GI cancer. A significant decrease in overall mean ETS score was observed between baseline and week 6 (p = 0.001) and 12 (p = 0.0004), respectively. Moreover, the mean MSAS psychological symptoms decreased significantly at week 12 compared to baseline (p = 0.005), while no change was observed in physical symptoms (p = 0.101). Of the 40 participants who completed baseline surveys, 37 had at least one additional visit for a drop-out rate of 7.5%. CONCLUSION This mixed-methods pilot study was successful in demonstrating the feasibility of distributing a standardized educational brochure as an intervention for chemotherapy patients. While participants' emotional scores and psychological symptoms decreased over time, physical symptoms did not, which aligns with side effect progression from cumulative chemotherapy burden.
Collapse
Affiliation(s)
- Shelby Labe
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Gavin Jones
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Hannah Dailey
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Joanna Bhasker
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Rhea Kanwar
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Madison Crago
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Britney Fitzgerald
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Daniella Mikhail
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Sonia Hafiz
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Courtney Kramer
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| | - Junjia Zhu
- Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA
| | - Monali Vasekar
- Department of Hematology and Oncology, Penn State Cancer Institute, Hershey, Pennsylvania, USA
| |
Collapse
|
2
|
Soqia J, Al-shafie M, Agha LY, Alameer MB, Alhomsi D, Saadoun R, Saifo M. Depression, anxiety and related factors among Syrian breast cancer patients: a cross-sectional study. BMC Psychiatry 2022; 22:796. [PMID: 36528568 PMCID: PMC9759902 DOI: 10.1186/s12888-022-04469-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Accepted: 12/13/2022] [Indexed: 12/23/2022] Open
Abstract
INTRODUCTION Breast cancer represents a traumatic experience with a psychological burden. The prevalence of psychological distress (which include depression and anxiety) among breast cancer patients is estimated to be 15 to 54%, but studies have shown that applying some psychological treatments has contributed to decreasing depression and anxiety. So, it is crucial to diagnose and treat patients with the appropriate means. After reviewing the literature, no studies discussed depression and anxiety among Syrian breast cancer patients. METHODS A cross-sectional study in Al-Bairouni hospital in Damascus, Syria carried out using face-to-face interviews based on a structured questionnaire. All breast cancer patients were included, except who refused to participate, and responses with missing data were excluded. The questionnaire consisted of 2 sections: the first included Socio-demographic characteristics, and the other evaluated patients' depression using PHQ-2 and GAD-2 scales. Data were gathered using the Kobo toolbox app and then entered into an Excel sheet. RESULTS Five hundred patients were interviewed. 35.6% of the patients had a GAD-2 score greater than or equal to 3.00, while 35% had a PHQ-2 score greater than or equal to 3.00. There is a significant negative relationship between the age of the patient and the GAD-2 score and PHQ-2 score, which means the older the patient is, the lower the GAD-2 and PHQ-2 scores are. A multivariable regression model showed that younger (age ≤ 45 years) and being widowed were associated with being positive for further evaluation for generalized anxiety disorder. Similarly, patients younger than 45 are significantly associated with the need for further evaluation for major depressive disorder (MDD). Social status had a stronger association with the need for further assessment for MDD, with divorced women showing the strongest association, followed by widowed and married women compared to single women. CONCLUSION This study showed high anxiety and depression among breast cancer patients. The patient's age and social status were significant factors in determining the need for further psychological assessment. In General, Younger patients showed higher levels of depression and anxiety, the size of the tumor did not show significant association with psychological distress.
Collapse
Affiliation(s)
- Jameel Soqia
- Faculty of Medicine, Damascus University, Damascus, Syria.
| | - Mohammed Al-shafie
- grid.8192.20000 0001 2353 3326Faculty of Medicine, Damascus University, Damascus, Syria
| | - Laila Yakoub Agha
- grid.8192.20000 0001 2353 3326Faculty of Medicine, Damascus University, Damascus, Syria
| | - Mhd Basheer Alameer
- grid.8192.20000 0001 2353 3326Faculty of Medicine, Damascus University, Damascus, Syria
| | - Dima Alhomsi
- grid.8192.20000 0001 2353 3326Faculty of Medicine, Damascus University, Damascus, Syria
| | - Rakan Saadoun
- grid.7700.00000 0001 2190 4373Medical Faculty Mannheim, Ruprecht Karls University Heidelberg, Mannheim, Germany ,Department of Otorhinolaryngology-Head and Neck Surgery, Mannheim Medical Center, Mannheim, Germany ,grid.412689.00000 0001 0650 7433 Department of Plastic Surgery, The University of Pittsburgh, Pittsburgh, USA
| | - Maher Saifo
- grid.8192.20000 0001 2353 3326Faculty of Medicine, Damascus University, Damascus, Syria
| |
Collapse
|
3
|
Dickerson JC, Ibeka P, Inoyo I, Oke OO, Adewuyi SA, Barry D, Bello A, Fasawe O, Garrity P, Habeebu M, Huang FW, Mulema V, Nwankwo KC, Remen D, Wiwa O, Bhatt AS, Roy M. Implementing Patient-Directed Cancer Education Materials Across Nigeria. JCO Glob Oncol 2021; 7:1610-1619. [PMID: 34860566 PMCID: PMC8654433 DOI: 10.1200/go.21.00233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
As access to cancer care expands in low-income countries, developing tools to educate patients is paramount. We took a picture booklet, which was initially developed by the nonprofit Global Oncology for Malawi and Rwanda, and adapted it for use in Nigeria. The primary goal was to assess acceptability and provide education. The secondary goals were (1) to describe the collaboration, (2) to assess knowledge gained from the intervention, (3) to assess patient understanding of their therapy intent, and (4) to explore patient's experiences via qualitative analysis. In this cross-continent collaboration supported by @StanfordCIGH, low literacy-friendly cancer education booklets developed by @GlobalOnc increased awareness and knowledge about cancer treatment in 4 diverse sites in Nigeria.![]()
Collapse
Affiliation(s)
- James C Dickerson
- Department of Medicine (Hematology and Oncology), Stanford University, Stanford, CA
| | - Paulette Ibeka
- Clinton Health Access Initiative, Inc, Abuja, Federal Capital Territory, Nigeria
| | - Itoro Inoyo
- Clinton Health Access Initiative, Inc, Abuja, Federal Capital Territory, Nigeria
| | | | - Sunday A Adewuyi
- Oncology, Ahmadu Bello University Teaching Hospital Zaria, Nigeria
| | | | - Abubakar Bello
- Radiotherapy, Lagos University Teaching Hospital, Idi Araba Lagos, Nigeria
| | - Olufunke Fasawe
- Clinton Health Access Initiative, Inc, Abuja, Federal Capital Territory, Nigeria
| | | | | | | | - Vivienne Mulema
- Clinton Health Access Initiative, Inc, Abuja, Federal Capital Territory, Nigeria
| | | | | | - Owens Wiwa
- Clinton Health Access Initiative, Inc, Abuja, Federal Capital Territory, Nigeria
| | - Ami S Bhatt
- Global Oncology Inc, Oakland, CA.,Department of Medicine (Hematology, Blood and Marrow Transplantation) and of Genetics, Stanford Center for Innovation in Global Health, Stanford University, Stanford, CA.,Global Oncology, Oakland, CA
| | - Mohana Roy
- Department of Medicine, Oncology, Stanford University, Stanford, CA
| |
Collapse
|